Search

Author/Creator Wyles, David L

1. 1979. Time to Viral Suppression Does Not Impact SVR in Patients Treated With Glecaprevir/Pibrentasvir for 8 Weeks. (26th November 2018)

Authors:
Sarrazin, Christoph; Tran, Tram; Dylla, Douglas; Feld, Jordan J; Arora, Sanjeev; Victor, David; Hu, Yiran B; Wang, Stanley; Mensa, Federico; Wyles, David L
Journal:
Open forum infectious diseases
Issue:
Volume 5(2018)Supplement 1
Page Start:
S574
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Continued Low Rates of Hepatitis C Virus (HCV) Recurrence in HCV/HIV- and HCV-Infected Participants Who Achieved Sustained Virologic Response After Direct-Acting Antiviral Treatment: Final Results From the AIDS Clinical Trials Group A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS). (14th October 2021)

Authors:
Wyles, David L; Kang, Minhee; Matining, Roy M; Murphy, Robert L; Peters, Marion G
Journal:
Open forum infectious diseases
Issue:
Volume 8:Number 12(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical Trials. (27th September 2018)

Authors:
Grebely, Jason; Puoti, Massimo; Wedemeyer, Heiner; Cooper, Curtis; Sulkowski, Mark S; Foster, Graham R; Berg, Thomas; Villa, Erica; Rodriguez-Perez, Federico; Wyles, David L; Schnell, Gretja; Alami, Negar N; Zhang, Zhenzhen; Dumas, Emily; Dore, Gregory J
Journal:
Open forum infectious diseases
Issue:
Volume 5:Number 11(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial. Issue 12 (December 2021)

Authors:
Kalil, Andre C; Mehta, Aneesh K; Patterson, Thomas F; Erdmann, Nathaniel; Gomez, Carlos A; Jain, Mamta K; Wolfe, Cameron R; Ruiz-Palacios, Guillermo M; Kline, Susan; Regalado Pineda, Justino; Luetkemeyer, Anne F; Harkins, Michelle S; Jackson, Patrick E H; Iovine, Nicole M; Tapson, Victor F; Oh, M...
Journal:
Lancet
Issue:
Volume 9:Issue 12(2021)
Page Start:
1365
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial. Issue 12 (December 2021)

Authors:
Kalil, Andre C; Mehta, Aneesh K; Patterson, Thomas F; Erdmann, Nathaniel; Gomez, Carlos A; Jain, Mamta K; Wolfe, Cameron R; Ruiz-Palacios, Guillermo M; Kline, Susan; Regalado Pineda, Justino; Luetkemeyer, Anne F; Harkins, Michelle S; Jackson, Patrick E H; Iovine, Nicole M; Tapson, Victor F; Oh, M...
Journal:
Lancet
Issue:
Volume 9:Issue 12(2021)
Page Start:
1365
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus–HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation. (14th May 2020)

Authors:
Anthony, Donald D; Sulkowski, Mark S; Smeaton, Laura M; Damjanovska, Sofi; Shive, Carey L; Kowal, Corinne M; Cohen, Daniel E; Bhattacharya, Debika; Alston-Smith, Beverly L; Balagopal, Ashwin; Wyles, David L
Journal:
Journal of infectious diseases
Issue:
Volume 222:Number 8(2020)
Page Start:
1334
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Intrahepatic Viral Kinetics During Direct-Acting Antivirals for Hepatitis C in Human Immunodeficiency Virus Coinfection: The AIDS Clinical Trials Group A5335S Substudy. (23rd March 2020)

Authors:
Balagopal, Ashwin; Smeaton, Laura M; Quinn, Jeffrey; Venuto, Charles S; Morse, Gene D; Vu, Vincent; Alston-Smith, Beverly; Cohen, Daniel E; Santana-Bagur, Jorge L; Anthony, Donald D; Sulkowski, Mark S; Wyles, David L; Talal, Andrew H
Journal:
Journal of infectious diseases
Issue:
Volume 222:Number 4(2020)
Page Start:
601
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Pharmacokinetics and renal safety of tenofovir alafenamide with boosted protease inhibitors and ledipasvir/sofosbuvir. (7th August 2020)

Authors:
Brooks, Kristina M; Castillo-Mancilla, Jose R; Morrow, Mary; MaWhinney, Samantha; Blum, Joshua; Wyles, David L; Rowan, Sarah E; Ibrahim, Mustafa E; Zheng, Jia-Hua; Johnson, Bethany; Gomez, Joe; Choi, Ye Ji; Cendali, Francesca; Haas, Hannah; Roon, Laura; Bushman, Lane R; Anderson, Peter L; Kiser, ...
Journal:
Journal of antimicrobial chemotherapy
Issue:
Volume 75:Number 11(2020)
Page Start:
3303
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗